# BioNexus Gene Lab Corp: Form 8-K, filed Jan 7, 2021

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2021-01-07
- Accepted by EDGAR: Jan 7, 2021, 16:00 ET
- Period: 2020-12-31
- Accession: 0001477932-21-000091
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793221000091/bion_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793221000091/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.01: Change in control
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793221000091/bion_8k.htm

Filed Jan 7, 2021.
Source: SEC EDGAR, the filing index for accession 0001477932-21-000091. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
